Anduril Stock Guide: How to Think About Your Anduril Equity Compensation and Stock Strategy
Anduril Stock Guide · Equity strategy
Anduril stock compensation can be one of the most valuable but also most complex parts of your total compensation.
Unlike equity at a public company, Anduril equity comes with uncertainty, limited liquidity, and real financial decisions around when and whether to exercise your options. In some cases, those decisions require committing significant personal capital without knowing exactly when you will be able to access that value.
Over time, many Anduril employees accumulate meaningful exposure to the company through vested options and RSUs. Because that equity is private, it is easy to underestimate both the risk and the opportunity.
This guide explains how Anduril's equity works and how to think through key decisions around exercising options, managing taxes, planning for liquidity, and aligning your equity with your long-term financial goals.
At a glance
Anduril stock compensation
Anduril is a private company, which means its stock is not publicly traded. Employees cannot freely sell shares and must rely on company-driven liquidity events.
Equity remains central to compensation, particularly for engineers, product managers, and senior hires. Most employees receive stock options upon joining, often alongside Restricted Stock Units.
Typical compensation components
| Equity type | Description |
|---|---|
| Anduril Stock Options (ISOs/NSOs) | The primary form of equity compensation |
| Anduril RSUs | Secondary form of equity compensation |
| Refresh Grants | Additional RSU grants are awarded periodically to retain employees |
| Refresh grants | Additional RSUs awarded periodically to retain employees. |
| Tender Offer Opportunities | Occasional internal liquidity events |
Vesting & liquidity
Anduril’s equity vesting schedule
Most Anduril equity grants vest over four years.
| Grant type | Vesting period | Cliff | Notes |
|---|---|---|---|
| ISOs | 4 years | 1 year | Initial grants follow this structure. After the cliff, shares vest in 12 quarterly installments. |
| NSOs | 4 year | 1 year cliff | Initial grants follow this structure. After the cliff, shares vest in 12 quarterly installments. |
| RSUs | 4 years | No cliff | Initial grants and refresh grants follow this structure. Shares vest in 12 quarterly installments. |
Why this matters
As options vest, employees gain the right to purchase shares, but must then decide whether and when to exercise them. That decision is meaningfully different from anything a public company employee faces.
Liquidity and Selling Shares
Because Anduril is a private company, vested equity is not immediately liquid. Employees cannot sell shares on demand. Liquidity typically occurs through one of three paths: a tender offer, an approved secondary market transaction (currently very limited), or a future IPO or acquisition.
As a result, employees may accumulate significant paper wealth without access to cash. This creates a key planning challenge. Exercising options often requires committing capital before liquidity exists, which means balancing long-term upside with short-term financial flexibility.
Behavior
Cultural patterns among Anduril employees
Anduril has a strong mission-driven culture, and many employees have deep conviction in the company's long-term impact. In practice, this often shows up as holding shares longer, not participating in tender offers due to belief in future upside, and being comfortable building large concentrated positions.
While that conviction can be well-founded, it can also lead to overexposure when decisions are made without intention.
The goal
The goal is not to reduce conviction. It is to pair it with structure, so your exposure reflects a plan, not a reaction.
Taxes
How Anduril equity is taxed
Anduril employees receive equity in three primary forms: ISOs, NSOs, and RSUs, and each is taxed differently. Understanding the mechanics of each is essential to avoiding surprise tax bills and making informed decisions about when and how to exercise or sell.
Incentive Stock Options (ISOs)
ISOs are not taxed at grant or exercise for regular income tax purposes, but the spread between the 409A fair market value and the strike price may trigger Alternative Minimum Tax at exercise.
Example
Example: If you exercise 1,000 ISOs at a $10 strike when the company's 409A valuation is $25, the $15,000 bargain element will be included in AMT income.
After exercise, your cost basis is the strike price ($10), and the holding period begins. Upon sale:
- If you meet the qualifying disposition requirements (at least two years from grant and at least one year from exercise), the entire gain is taxed as long-term capital gains.
- If you do not meet those thresholds, the spread at exercise is taxed as ordinary income, and any additional gain is taxed as capital gains.
Non-Qualified Stock Options (NSOs)
NSOs are taxed as ordinary income at exercise on the spread between the 409A valuation and the strike price.
Key planning consideration
Taxes are due at exercise even if the shares are illiquid.
Example
Example: Exercise 1,000 NSOs at $10 when the 409A value is $25, and you recognize $15,000 of ordinary income, reported on your W-2 if you are still employed or on a 1099 if you are not.
Your cost basis becomes $25 per share. Shares held for more than one year after exercise qualify for long-term capital gains treatment on any subsequent appreciation.
Restricted Stock Units (RSUs)
Anduril RSUs now follow a single-trigger framework. Time-based vesting is sufficient for vested RSUs to settle into shares of Anduril common stock, without requiring an IPO, acquisition, or other liquidity event. RSUs continue to vest quarterly and generally settle on Anduril's semiannual settlement schedule. At settlement, the fair market value of the shares is taxed as ordinary compensation income and reported on your W-2.
Key planning consideration
Vesting and settlement are separate events. RSUs vest quarterly, but taxable income is generally recognized when the vested units settle into common stock on the semiannual settlement dates. Because Anduril remains private, the resulting shares may still be illiquid even though tax is due at settlement.
Example
100 RSUs settle when the stock is valued at $25, resulting in $2,500 of ordinary income. If you later sell at $50, the $25 gain per share is taxed based on your holding period from the settlement date.
Side-by-side comparison
| ISOs | NSOs | RSUs | |
|---|---|---|---|
| Taxable event | Exercise (AMT) + Sale | Exercise | Settlement (vesting + liquidity event) |
| Income character | AMT at exercise; capital gains at sale | Ordinary income at exercise | Ordinary income at settlement |
| Taxable amount | Spread (409A FMV minus strike) for AMT | Spread (409A FMV minus strike) | FMV at semi-annual settlement dates until IPO |
| Appears on W-2 | No (AMT preference item) | Yes | Yes |
| Cost basis after event | Strike price | FMV at excercise | FMV at settlement |
| LT capital gains eligibility | 2+ years from grant and 1+ year from exercise | 1+ year post-exercise on incremental gain | 1+ year post-settlement on incremental gain |
A note on state taxes
Federal rates are only part of the picture. Many Anduril employees work and live in California, where the top marginal state income tax rate is 13.3%. Combined with a 37% federal rate and 2.35% Medicare, including the Additional Medicare Tax on high earners, the all-in marginal rate on exercise or settlement income can exceed 52% for employees in the highest brackets.
Even employees in lower-tax states should factor in state ordinary income tax on these events. If you relocate between grant and vest, or between vest and sale, multi-state tax allocation rules can apply and add further complexity.
Planning note
Working with a financial planner and tax advisor ahead of major exercise decisions or vesting events, not after, is the most effective way to manage this exposure.
The key decision
Exercise, Hold, or Wait
With Anduril stock options, the core decision is not simply whether to sell. It is whether to exercise your options, continue holding them unexercised, or wait.
Exercising requires real capital and may introduce tax consequences without any corresponding liquidity.
The reframe
If you had to write a check today to invest in Anduril, would you do it? Beyond that, consider how much capital you are willing to commit, what percentage of your net worth this represents, your expected timeline for liquidity, and your risk tolerance.
Three paths, not two
Most conversations about stock options default to a binary: exercise or wait. In practice, a third option is often the most sensible: exercise partially.
A partial exercise lets you establish a cost basis and start the long-term capital gains clock on a portion of your options while preserving cash and flexibility on the rest. For many Anduril employees, this approach is easier to execute financially than a full exercise and more strategic than doing nothing.
The right mix depends on your current cash position, how much of your net worth you are willing to tie to an illiquid asset, whether Anduril has a realistic near-term liquidity path, and your AMT exposure in the exercise year.
A framework for the decision
There is no universal right answer, but a few reference points can help anchor the decision.
01 · Concentration
Use it as a guide
Holding may be reasonable when PLTR is less than 10–20% of your total investable assets. Above that, concentration risk often outweighs the upside of holding, regardless of conviction. Remember salary, bonus, and future grants are also tied to the company.
02 · Capital at Risk
Test your downside
Before exercising, ask whether you would be comfortable if the capital you commit, including the strike price plus any AMT, went to zero. Private companies can and do fail. If that outcome would materially change your financial plan, scale back.
03 · Liquidity
Know your time horizon
Exercising early is most valuable when a liquidity event is plausible within your holding period. If there is no clear path to an IPO, acquisition, or tender offer in the next several years, the tax benefits of early exercise lose some of their appeal.
04 · AMT
Model the tax window
For ISOs, the AMT preference item is often the largest variable in the exercise decision. Running an AMT projection before exercising—ideally with a CPA—can be the difference between a tax-efficient strategy and an expensive surprise.
Make it a system, not a series of one-off decisions
The most effective approach is to establish a clear exercise strategy before options vest, not when the company announces something or the 409A valuation moves. Emotional reactions to recent news or price changes are one of the most reliable ways to make poor long-term decisions with private equity.
A pre-committed framework, whether a personal policy of exercising a defined percentage at each vesting milestone, a concentration ceiling, or a liquidity-triggered plan, removes the decision from the moment and anchors it to your financial plan.
The bottom line
Exercising Anduril options should be an active financial decision, made with full awareness of your capital at risk, tax situation, and liquidity timeline, not the default outcome of doing nothing.
Our philosophy
DiversiFi's default approach
Our general philosophy is to treat Anduril stock, ISOs, NSOs, and RSUs alike, as optionality first and current wealth second.
This distinction matters. Until a liquidity event occurs, the value of your Anduril stock is theoretical, while the costs of holding it, including exercise capital, potential AMT, and opportunity cost on that capital, are very real. Framed that way, the question becomes: how much of your financial life can you reasonably tie up in an illiquid asset with an uncertain timeline?
For most clients, the answer points toward exercising deliberately and in pieces, keeping a meaningful portion of net worth diversified outside the company, and treating any liquidity event as a planning opportunity rather than a windfall to reinvest back into the same position.
Not one-size-fits-all
Your cash position, AMT exposure, grant structure, income stability, and conviction in Anduril all factor into what makes sense for you specifically. Our role is to help you build a strategy that reflects your full financial picture, not a generic default.
What we typically see works well
In our experience working with Anduril employees, the clients who navigate equity compensation most effectively tend to share a few common traits. They make exercise decisions deliberately rather than reactively. They maintain a clear picture of their total Anduril exposure, including unexercised options, unvested RSUs, and salary dependence, not just what has already vested or been exercised. And they separate their belief in Anduril as a company from their decision about how much illiquid, concentrated exposure their financial plan can actually absorb.
Those are separable questions. You can have deep conviction in Anduril's mission and still conclude that committing another $200,000 to an illiquid position carries more risk than your financial plan warrants.
Our starting point
When we work with a new Anduril client, we begin by mapping their full equity picture: what has vested, what is unexercised, what the approximate tax liability looks like under different exercise scenarios, and what the resulting concentration would be under different hold and exercise paths.
From there, we build a personalized equity strategy, which may include a phased exercise plan, a concentration ceiling, a plan around tender offer participation, or a combination, anchored to their specific goals rather than a generic rule.
A note on our philosophy
We are not reflexively anti-concentration. Holding Anduril stock can be a sound decision for the right client in the right circumstances. Our goal is simply to ensure that when clients exercise or hold, they do so intentionally, with a clear rationale, an awareness of the risks, and a plan for how that decision fits into their broader financial life.
Decision framework
When exercising vs. waiting may make sense
Neither exercising nor waiting is inherently right. The answer depends on your full financial picture, risk tolerance, liquidity needs, and the amount of capital you are willing to commit to an illiquid investment.
1 Concentration is manageable
If Anduril represents less than 10–15% of your investable assets, exercising additional options may add meaningful upside without creating outsized single-company risk. Beyond that range, the decision requires a stronger and more specific rationale.
2 You have a defined thesis
You can clearly explain why you believe Anduril may deliver a meaningful return over your time horizon, based on a specific view of the company’s trajectory rather than a general belief that its value will rise.
3 Income isn’t Anduril-dependent
Concentration risk increases when both your wealth and paycheck are tied to the same company. If your financial life outside of Anduril equity is stable and diversified, a concentrated position may carry less overall risk.
4 You have liquidity elsewhere
Exercising makes more sense when you have sufficient liquid assets for near-term goals, emergency reserves, and planned expenses without depending on Anduril equity to become liquid on a specific timeline.
5 You have a plan to revisit
Define in advance when you will reassess the position, such as when it reaches a concentration threshold, the company’s liquidity outlook changes, or your personal circumstances shift. Conviction without a review framework is not a complete plan.
1 The exercise would consume too much capital
If the strike price plus potential AMT would require a meaningful portion of your liquid assets, exercising creates a substantial commitment to an illiquid position. Preserving flexibility may be more valuable than starting the capital-gains holding period early.
2 Income and wealth both depend on Anduril
When salary, bonus, unvested equity, and personal investments are all tied to one company, your exposure is already significant. A large exercise adds further illiquid concentration to that risk.
3 There is no clear liquidity path
Early exercise is most valuable when an IPO, acquisition, or meaningful tender offer is plausible within your expected holding period. Without a realistic liquidity timeline, the benefits of exercising early may be more limited.
4 You lack a clear thesis
If the decision is driven primarily by urgency, fear of missing out, or a vague belief that the company will do well, it may be worth pausing. A large commitment to an illiquid asset deserves a specific and defensible reason.
5 The tax timing is favorable
Exercising during a high-income year, especially when ISOs create significant AMT exposure, can produce a substantial tax bill without liquidity to fund it. Waiting for a lower-income year or a clearer liquidity horizon may reduce the cost of exercising.
A note on framing
These scenarios are decision-making reference points, not a prescription. The appropriate strategy depends on how Anduril equity fits within your broader financial plan.
The core risk
Understanding concentration risk
Concentration risk is owning too much of one asset, and private company equity introduces both concentration risk and liquidity risk simultaneously. Many Anduril employees underestimate this exposure because the value of their equity is theoretical until a liquidity event occurs. There are three primary risks:
Risk 01
Career risk
Your income and your equity are tied to the same company. A downturn that affects the business could affect both simultaneously.
Risk 02
Liquidity risk
Even if the company performs well, you may not be able to access the value of your shares for years. This is a materially different risk profile than public company equity.
Risk 03
Opportunity cost
Capital tied up in one illiquid position cannot be deployed elsewhere, whether into a diversified portfolio, real estate, or other opportunities that arise in the meantime.
DiversiFi concentration guidelines
| % of net worth in Anduril | Our view |
|---|---|
| Under 10% | Generally manageable |
| 10–20% | Monitor closely |
| 20–50% | Active diversification recommended |
| Over 50% | High concentration risk |
For private companies
These thresholds often warrant even greater caution than for public equity, given the added liquidity risk. Employees with other single-stock exposure should adjust their personal threshold downward accordingly.
Strategies
Managing concentration over time
Unlike public stock, private company equity can't always be sold when you choose. Because liquidity is limited, managing concentration is typically an ongoing process rather than a one-time decision. Most employees gradually reduce risk over time while preserving participation in the company's long-term upside.
| Strategy | Approach |
|---|---|
| Exercise gradually | Spread option exercises over multiple years to manage taxes, reduce AMT exposure, and avoid committing too much capital at once. |
| Participate in tender offers | Use company-sponsored liquidity events to reduce concentration while retaining meaningful ownership. |
| Explore secondary transactions | If permitted under Anduril's policies, secondary sales may provide liquidity before an IPO or acquisition. |
| Diversify outside Anduril | Build and maintain a diversified liquid investment portfolio so your financial future isn't dependent on one private company. |
What most clients land on
Most DiversiFi clients take a layered approach rather than relying on a single strategy. Gradual exercises, opportunistic tender offers, and disciplined diversification often work together to reduce concentration while preserving exposure to Anduril's long-term potential.
Case study
Example Anduril Employee with a Large Option Position
Hypothetical
The following is a hypothetical example based on the type of situation we commonly encounter with Anduril employees.
| Metric | Value |
|---|---|
| Net worth | $1.8M |
| Vested options | Large position |
| Exercise cost | $300K |
This employee had built a meaningful position in Anduril and was considering exercising a large portion of their options all at once. On paper, the decision seemed straightforward. The company was performing well, and there was strong internal conviction about its future.
But exercising would have required committing $300K of personal capital and potentially triggering significant taxes, all without a clear timeline for liquidity. The real question became less about upside and more about risk concentration and financial flexibility.
Rather than exercising everything immediately, the employee chose a more structured approach. They exercised a portion of their options over time, keeping their total Anduril exposure within a defined percentage of their net worth while maintaining liquidity outside the company.
This allowed them to stay meaningfully invested in Anduril's potential upside without putting themselves in a position where too much of their financial life was tied to a single, illiquid asset.
A note on this example
This is a hypothetical illustration, not a guarantee of outcomes. Actual results depend on the company's trajectory, tax circumstances, and individual planning decisions. The planning framework, however, remains sound regardless of how the company performs.
DiversiFi's perspective
Building wealth without putting your future at risk
Private company equity can be one of the most powerful drivers of long-term wealth. For many Anduril employees, stock options and RSUs represent years of compounding potential and a genuine opportunity to build lasting financial security.
But that potential comes with real risks around concentration, liquidity, and taxes that are easy to underestimate when equity value exists only on paper. The employees who build the most durable financial lives from private equity are rarely those who simply exercised the most. They are the ones who had a plan for when to exercise, how much to commit, how to manage the tax complexity, and what the equity was ultimately for.
In one line
Diversification does not mean you believe less in the company. It simply means protecting your financial future while still participating in its upside.
At DiversiFi, we help Anduril employees turn private equity into a deliberate financial strategy by aligning exercise decisions with tax planning, liquidity expectations, and long-term goals. Every client's situation is different, but the process is consistent: understand the full picture first, build a personalized plan second, and execute it with discipline over time.
Is it time to build your plan?
If a meaningful portion of your net worth is tied to Anduril equity, or will be after upcoming vesting events, the most valuable thing you can do right now is get a clear picture of where you stand.
That means understanding your total Anduril exposure across exercised shares, unexercised options, and unvested grants. It means knowing what your tax liability looks like under different exercise scenarios. And it means having a strategy for what you want to do with the equity you have earned, not as a series of one-off decisions, but as a coherent plan tied to the life you are building.
That is exactly what we work through with new clients in an initial equity planning session. There is no obligation and no generic advice, just a focused conversation about your specific situation and what a plan built around it would look like.
Schedule a free consultation →
DiversiFi Capital Inc is a registered investment adviser located in CA and may only transact business or render personalized investment advice in those states and international jurisdictions where we are registered, notice filed, or where we qualify for an exemption or exclusion from registration requirements. Any communications with prospective clients residing in jurisdictions where DiversiFi Capital Inc is not registered or licensed shall be limited so as not to trigger registration or licensing requirements.
DiversiFi Capital is not affiliated with, endorsed by, or sponsored by any company, organization, or product referenced herein.
The Information presented in our blog posts is intended for educational purposes only. It is not intended to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Unless otherwise stated, the investments discussed in our blog posts are not guaranteed.
The content in our blog posts is designed to provide information and insights, but should not be used as the sole basis for making financial decisions. The content provided in our blog post(s) is provided “as is,” and/or “as available.” DiversiFi Capital Inc will, to the best of its abilities, maintain the content to be up to date. However, DiversiFi Capital Inc does not represent or warrant that our content or our services found within are accurate, complete, reliable, current, or error-free.
Tax information provided is intended as a general educational overview and should not be construed as tax advice. You should consult your tax professional for clarification and any additional questions prior to implementation.
Case studies presented are based on actual clients, however, some of the information may have been changed or altered. These studies are provided for educational purposes only. Similar or even positive results cannot be guaranteed. Each client has their own unique set of circumstances, so products and strategies may not be suitable for all people. Please consult with a qualified professional before implementing any strategy discussed herein.
We strongly encourage readers to conduct their own research, seek advice from qualified financial professionals, and consider their unique financial circumstances before making any investment or financial decisions. Your individual situation may vary, and it's essential to make informed choices that align with your specific goals and needs.
Past performance is not indicative of future returns, and investing always carries inherent risks, including the potential loss of principal capital. Any investment strategies are specific to individual clients and may not be representative of the experiences of all clients.